Abstract
Injectable gel implants using poly(lactic-co-glycolic) acid (PLGA) for methotrexate were prepared. In-vitro release was observed for 10-12 days and was dependent on PLGA concentration. The antitumour efficacy in mice bearing sarcoma-180 was improved as revealed by the volume doubling time. The drug plasma levels were sustained for more than 2 weeks.
Original language | English |
---|---|
Pages (from-to) | 133-136 |
Number of pages | 4 |
Journal | Pharmaceutical Sciences |
Volume | 3 |
Issue number | 3 |
Publication status | Published - 1997 |
All Science Journal Classification (ASJC) codes
- Pharmaceutical Science